Form 8-K - Current report:
SEC Accession No. 0001213900-25-084618
Filing Date
2025-09-04
Accepted
2025-09-04 17:28:28
Documents
12
Period of Report
2025-08-29
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0256084-8k_profusa.htm   iXBRL 8-K 26315
  Complete submission text file 0001213900-25-084618.txt   193497

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nvacw-20250829.xsd EX-101.SCH 3014
3 XBRL LABEL FILE nvacw-20250829_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE nvacw-20250829_pre.xml EX-101.PRE 22357
14 EXTRACTED XBRL INSTANCE DOCUMENT ea0256084-8k_profusa_htm.xml XML 3785
Mailing Address 207 WEST 25TH ST, 9TH FLOOR NEW YORK NY 10001
Business Address 207 WEST 25TH ST, 9TH FLOOR NEW YORK NY 10001 212-494-9022
Profusa, Inc. (Filer) CIK: 0001859807 (see all company filings)

EIN.: 863437271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41177 | Film No.: 251294404
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)